Author:
Sauter Max,Uhl Philipp,Burhenne Jürgen,Haefeli Walter E.
Funder
German Federal Ministry of Education and Research (BMBF
Physician Scientist program of the Faculty of Medicine of Heidelberg University, Germany
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference17 articles.
1. The Female Sexual Response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder;Kingsberg;CNS Drugs,2015
2. Multidiscipline Review NDA 210557 Vyleesi,2019
3. Long-term safety and efficacy of bremelanotide for hypoactive sexual desire disorder;Simon;Obstet. Gynecol.,2019
4. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction;Diamond;Int. J. Impot. Res.,2004
5. Hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health;Lodise;Pharmacotherapy,2013
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献